Moody Aldrich Partners LLC Novavax Inc Transaction History

Moody Aldrich Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$121.0 - $257.67 $1.72 Million - $3.65 Million	-14,180 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$112.98 - $319.93 $888,587 - $2.52 Million	-7,865 Reduced 35.68%	14,180 $2.57 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $1,259 - $2,232	-16 Reduced 0.07%	22,045 $2.46 Million
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $206,226 - $463,411	-2,596 Reduced 10.53%	22,061 $2.39 Million
Q2 2020 Jul 30, 2020	BUY	$13.86 - $83.61 $341,746 - $2.06 Million	24,657 New	24,657 $2.06 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.